Sex reassignment of transsexuals is associated with increased mortality, psychiatric morbidity
|
|
Dr Cecilia Dhejne |
Sex reassignment is the treatment of transsexualism, little is known about the long-term outcome regarding mortality and psychiatric health of this procedure. We performed a retrospective case-control study based on Swedish national register data from 1973-2003, in which 324 sex reassigned individuals were identified and matched to two sets of randomly selected controls
(10 for each case): one matched by birth sex; one matched by sex at end of follow-up. Hazard ratios with 95% CIs were calculated from Cox proportional hazards regression.
Findings: The sex reassigned group had three times higher mortality rate than the reference group matched for birth age and birth sex, after adjustment for psychiatric morbidity and immigrant status prior to baseline (Hazard ratio [HR] 2.8; 95% CI 1.8-4.3). The risk for death by suicide was much higher than in the reference group (HR 19.1; 95% CI 5.8–62.9).There was also a marked increased risk for psychiatric in-patient care (HR 2.8; 95% CI 2.0–3.9) and suicide attempts (HR 4.9; 95% CI 2.9–8.5), also when adjusting for psychiatric morbidity prior to baseline. Sex reassigned individuals have substantially higher mortality and are at higher risk for psychiatric morbidity and suicide attempts than the normal population. To reduce the risk of suicide it is important that clinicians don’t neglect the psychiatric co-morbidity. More research is needed to prevent and elucidate the causes of higher mortality rates for sex reassigned individuals.
Conflict of Interest: None disclosed
Financial Support/Funding: Financial Support/Funding:Swedish psychiatry fondation, svenska psykiatrifonden
Recorded at 19th WAS World Congress for Sexual Health - Sexual Health & Rights: A Global Challenge Göteborg (Sweden) - June 21 – 25, 2009
|
Cecilia Dhejne
|
Dr Cecilia Dhejne
|
MD, consultant in psychiatry, authorized clinical sexologist ( NACS). Gender team and Center for Andrology and Sexual Medicine, Karolinska University Hospital Huddinge Stockholm Sweden. Department of Clinical Neuroscience, Section of Psychiatry, Karolinska Institutet, Stockholm, Sweden.
|
Co-authors: Långström, Niklas (Department of Clinical Neuroscience, Section of Psychiatry, Karolinska Institutet, Stockholm Sweden and Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden ), Lichtenstein Paul (Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden ), Boman Marcus (Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden ), Johansson Anna (Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden), Landen Mikael (Department of Clinical Neuroscience, Section of Psychiatry, Karolinska Institutet, Stockholm Sweden and Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden)
Navigation
......................................
......................................
......................................
|
Help
......................................
......................................
......................................
|
Audio Visual Archives
......................................
......................................
......................................
|
Useful
......................................
......................................
......................................
|
|
|
|